Cargando…

Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia

BACKGROUND: The role and mechanism of action of MIF in bronchopulmonary dysplasia (BPD) are not known. We hypothesized that increased MIF signaling would ameliorate the pulmonary phenotype of BPD in the mouse lung. METHODS: We studied newborn wild type (WT), MIF knockout (MIFKO), and lung MIF transg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Huanxing, Choo-Wing, Rayman, Fan, Juan, Leng, Lin, Syed, Mansoor A, Hare, Alissa A, Jorgensen, William L, Bucala, Richard, Bhandari, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637059/ https://www.ncbi.nlm.nih.gov/pubmed/23448134 http://dx.doi.org/10.1186/1465-9921-14-27

Ejemplares similares

A Critical Regulatory Role for Macrophage Migration Inhibitory Factor in Hyperoxia-Induced Injury in the Developing Murine Lung
por: Sun, Huanxing, et al.
Publicado: (2013)

A potential role of the JNK pathway in hyperoxia-induced cell death, myofibroblast transdifferentiation and TGF-β1-mediated injury in the developing murine lung
por: Li, Zhang, et al.
Publicado: (2011)

miR34a: a master regulator in the pathogenesis of bronchopulmonary dysplasia
por: Das, Pragnya, et al.
Publicado: (2018)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitgation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia
por: Gilfillan, Margaret, et al.
Publicado: (2020)

Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies
por: Giusto, Kiersten, et al.
Publicado: (2021)

Effects of Hyperoxia on Mitochondrial Homeostasis: Are Mitochondria the Hub for Bronchopulmonary Dysplasia?
por: Xuefei, Yu, et al.
Publicado: (2021)

Patho-mechanisms of the origins of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2021)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Correction to: Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitigation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia
por: Gilfillan, Margaret, et al.
Publicado: (2020)

Recent advances in understanding and management of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2020)

Can biomarkers be used to predict bronchopulmonary dysplasia?()
por: Bhandari, Vineet, et al.
Publicado: (2020)

Hyperoxia Exacerbates Postnatal Inflammation-Induced Lung Injury in Neonatal BRP-39 Null Mutant Mice Promoting the M1 Macrophage Phenotype
por: Syed, Mansoor A., et al.
Publicado: (2013)

Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia
por: Lal, Charitharth Vivek, et al.
Publicado: (2018)

Role of Nitric Oxide Isoforms in Vascular and Alveolar Development and Lung Injury in Vascular Endothelial Growth Factor Overexpressing Neonatal Mice Lungs
por: Syed, Mansoor A., et al.
Publicado: (2016)

Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
por: Endesfelder, Stefanie, et al.
Publicado: (2019)

Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia
por: Balany, Jherna, et al.
Publicado: (2015)

Drug Therapy Trials for the Prevention of Bronchopulmonary Dysplasia: Current and Future Targets
por: Bhandari, Vineet
Publicado: (2014)

S-endoglin expression is induced in hyperoxia and contributes to altered pulmonary angiogenesis in bronchopulmonary dysplasia development
por: Lee, Yeongseok, et al.
Publicado: (2020)

Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice
por: Long, Yanrong, et al.
Publicado: (2022)

Claudin-18 expression under hyperoxia in neonatal lungs of bronchopulmonary dysplasia model rats
por: Zuo, Jingye, et al.
Publicado: (2022)

Non-Invasive Ventilatory Strategies to Decrease Bronchopulmonary Dysplasia—Where Are We in 2021?
por: Dumpa, Vikramaditya, et al.
Publicado: (2021)

MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia
por: Dong, Jie, et al.
Publicado: (2012)

Hyperoxia-induced methylation decreases RUNX3 in a newborn rat model of bronchopulmonary dysplasia
por: Zhu, Yuting, et al.
Publicado: (2015)

Cell Division Cycle 2 Protects Neonatal Rats Against Hyperoxia-Induced Bronchopulmonary Dysplasia
por: Li, Zhongying, et al.
Publicado: (2020)

How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow”
por: Nelin, Leif D., et al.
Publicado: (2017)

Progressive Vascular Functional and Structural Damage in a Bronchopulmonary Dysplasia Model in Preterm Rabbits Exposed to Hyperoxia
por: Jiménez, Julio, et al.
Publicado: (2016)

Low-Dose Vitamin D Protects Hyperoxia-Induced Bronchopulmonary Dysplasia by Inhibiting Neutrophil Extracellular Traps
por: Chen, Cuie, et al.
Publicado: (2020)

Mitochondrial Fission-Mediated Lung Development in Newborn Rats With Hyperoxia-Induced Bronchopulmonary Dysplasia With Pulmonary Hypertension
por: Dai, Yuanyuan, et al.
Publicado: (2021)

CD8A is a Promising Biomarker Associated with Immunocytes Infiltration in Hyperoxia-Induced Bronchopulmonary Dysplasia
por: Du, Yiting, et al.
Publicado: (2023)

1677 Macrophage migration inhibitory factor (MIF) promotes clearance of pneumococcal colonization
por: Das, Rituparna, et al.
Publicado: (2014)

SOX4 arrests lung development in rats with hyperoxia-induced bronchopulmonary dysplasia by controlling EZH2 expression
por: Pan, Bingting, et al.
Publicado: (2017)

Interleukin-33 (IL-33) Increases Hyperoxia-Induced Bronchopulmonary Dysplasia in Newborn Mice by Regulation of Inflammatory Mediators
por: Tang, Xiqin
Publicado: (2018)

METTL3 promotes hyperoxia-induced pyroptosis in neonatal bronchopulmonary dysplasia by inhibiting ATG8-mediated autophagy
por: Xu, Lili, et al.
Publicado: (2023)

Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis
por: Bezdek, Siegfried, et al.
Publicado: (2018)

Crystallographic and Receptor Binding Characterization of Plasmodium falciparum Macrophage Migration Inhibitory Factor Complexed to Two Potent Inhibitors
por: Pantouris, Georgios, et al.
Publicado: (2014)

2598. Macrophage Migration Inhibitory Factor May Contribute to Disseminated Coccidioidomycosis Susceptibility
por: Odio, Camila D, et al.
Publicado: (2019)

Macrophage Migration Inhibitory Factor is not Associated with Sarcoidosis Susceptibility or Severity in Whites or Blacks
por: Odio, Camila D., et al.
Publicado: (2020)

Macrophage Migration Inhibitory Factor Deficiency Augments Doxorubicin‐Induced Cardiomyopathy
por: Xu, Xihui, et al.
Publicado: (2013)

Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
por: Sheth, Sudip, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_berh04tvm6ltqs0tkpkd50174r